Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQW051 on Cognition in Stable Schizophrenia
NCT01730768Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AQW051 in schizophrenia, sponsored by Novartis. Started Sep 2012; status: completed.
02
Drugs
AQW051
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01730768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730768.